Patent · US Active

Influenza vaccine

US10485863B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignees

Novavax AB · SE
Erasmus University Rotterdam Medical Center · NL

Inventors

Albertus D. M. E. Osterhaus · Bunnik, NL
Bror Morein · Uppsala, SE
Karin Lövgren Bengtsson · Uppsala, SE

Key dates

Filing date	Jul 25, 2011
Grant date	Nov 26, 2019
Priority date	—
Expiry date	May 19, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a composition comprising at least one ISCOM complex and at least one ectodomain from at least one hemagglutinin (HA) domain and at least one ectodomain from at least one neuraminidase (NA) domain from one or more influenza virus, wherein the extodomains represent ectodomains isolated from the influenza virus. The invention also regards a kit. The composition may be used as an immune stimulating medicine, immune modulating pharmaceutical or a vaccine e.g. against influenza for vertebrates, e.g. birds and mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.